Tocagen Inc Human Resources Contracts & Agreements
27 Contracts & Agreements
- Bonus & Incentive Agreements (10 contracts)
- Change of Control Agreements (1)
- Compensation Agreements (5)
- Employment Agreements (10)
- Separation Agreements (1)
- Amended and Restated 2021 Equity Incentive Plan (Filed With SEC on August 22, 2024)
- Separation Agreement and Release by and between the Company and Hubert Chen, dated March 17, 2024 (Filed With SEC on May 13, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 18, 2024)
- Amended and Restated 2021 Equity Incentive Plan, and forms of agreements thereunder (Filed With SEC on March 18, 2024)
- Amended and Restated 2021 Equity Incentive Plan (Filed With SEC on September 20, 2023)
- Form of Change in Control and Severance Agreement (Filed With SEC on November 14, 2022)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 15, 2022)
- Forte Biosciences, Inc. 2021 Equity Incentive Plan (Filed With SEC on March 31, 2022)
- Amended and Restated Executive Employment Agreement, dated February 21, 2020, by and between the Registrant and Fairooz Kabbinavar M.D (Filed With SEC on February 27, 2020)
- Amended and Restated Executive Employment Agreement, dated February 21, 2020, by and between the Registrant and Douglas Jolly, Ph.D (Filed With SEC on February 27, 2020)
- Amended and Restated Executive Employment Agreement, dated February 21, 2020, by and between the Registrant and Mark Foletta (Filed With SEC on February 27, 2020)
- Amended and Restated Executive Employment Agreement, dated February 21, 2020, by and between the Registrant and Martin J. Duvall (Filed With SEC on February 27, 2020)
- Executive Employment Agreement, dated February 26, 2019, by and between the Registrant and Fairooz Kabbinavar M.D (Filed With SEC on August 8, 2019)
- Executive Employment Agreement, dated April 8, 2019, by and between the Registrant and Harry E. Gruber, M.D (Filed With SEC on August 8, 2019)
- Tocagen Inc. 2017 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on February 27, 2019)
- Tocagen Inc. 2017 Equity Incentive Plan, as amended, and Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on November 8, 2018)
- Executive Employment Agreement, dated February 12, 2018, by and between the Registrant and Douglas Jolly, Ph.D (Filed With SEC on March 9, 2018)
- Executive Employment Agreement, dated February 12, 2018, by and between the Registrant and Asha Das, M.D (Filed With SEC on March 9, 2018)
- Amended and Restated Executive Employment Agreement, dated February 12, 2018, by and between the Registrant and Mark Foletta (Filed With SEC on March 9, 2018)
- Amended and Restated Executive Employment Agreement, dated February 12, 2018, by and between the Registrant and Martin J. Duvall (Filed With SEC on March 9, 2018)
- Tocagen Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 9, 2018)
- Tocagen Inc. Annual Incentive Plan (Filed With SEC on August 9, 2017)
- TOCAGEN INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on April 3, 2017)
- TOCAGEN INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 31, 2017 APPROVED BY THE STOCKHOLDERS:MARCH 31, 2017 IPO DATE: (Filed With SEC on April 3, 2017)
- TOCAGEN INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 9, 2017)
- TOCAGEN INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: APPROVED BY THE STOCKHOLDERS: IPODATE: (Filed With SEC on March 9, 2017)
- TOCAGEN INC. 2009 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD: MARCH 23, 2009 APPROVED BY THE STOCKHOLDERS: MARCH 23, 2009 AMENDED BY THE BOARD: FEBRUARY 16, 2012 APPROVED BY THE... (Filed With SEC on March 9, 2017)
